Tubulysin D exhibits potent antitumor activity by inhibiting tubulin polymerization, leading to cell cycle arrest and apoptosis; it demonstrates highly potent cytotoxic activity against mammalian cancer cell lines, including multidrug-resistant strains, with IC50 values of 4.7 pM (HL60), 3.1 pM (HCT116), 670 pM (MCF7), and 13 pM (A549) in antiproliferative assays; its target IC50 for tubulin is 1.7 μM.